Regeneron Pharmaceuticals, Inc.

750,22 USD -4,65 (-0,62%)
Bid 746,48 USD
Ask 750,22 USD

Premiumpartner

Firmenbeschreibung

Regeneron Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen. Der Konzern erforscht, entwickelt, produziert und vermarktet Medikamente zur Behandlung schwerer Erkrankungen mit Fokus auf humane Antikörpertechnologien. Regeneron Pharmaceuticals vermarktet drei Produkte in den USA: EYLEA® (aflibercept) Injektion zur Behandlung der feuchten altersbedingten Makula-Degeneration der Augen, ZALTRAP® (ziv-aflibercept) Injektion in Zusammenarbeit mit Sanofi zur Behandlung von Patienten mit metastatischem kolorektalem Krebs und ARCALYST® (rilonacept) Injektion zur Senkung der Harnsäure bei Gichtpatienten zur Vorbeugung von Gichtanfällen. Weitere Produktkandidaten befinden sich in Forschungs- und Entwicklungsprogrammen zur Behandlung von Entzündungen, Krebs und Hypercholesterinämie.

KeyData

endOfFinancialYear: 31.12.2024 00:00
stockholderStructure: FMR LLC. (9.52078%),Vanguard Group (8.15586%),BlackRock Inc. (7.96338%),JP Morgan Chase & Co. (6.66877%),Capital World Investors (4.73435%),State Street Corporation (4.52281%),Capital International Investors (2.69082%),Dodge & Cox (2.18486%),GEODE CAPITAL MANAGEMENT LLC (2.17244%),LOOMIS SAYLES CO L P (1.12494%)
sharesOutstanding: 108072385.0000
ceo: Dr. Leonard S. Schleifer
board: Robert E. Landry, Dr. George D. Yancopoulos
supervisoryBoard: Arthur F. Ryan, Christine A. Poon, Craig B. Thompson, Dr. Bonnie L. Bassler, Dr. George D. Yancopoulos, Dr. Leonard S. Schleifer, Dr. Marc Tessier-Lavigne, George L. Sing, Huda Y. Zoghbi, M.D., Joseph L. Goldstein, M.D., Michael S. Brown, M.D., Tony Coles, M.D.
countryID: 20
freeFloat: 68.4000
faceValue: 0.0010
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Biotechnologie
industryName: Biotechnologie
subsectorName: Biotechnologie
country: USA
countryName: USA

Kontakt

phone: +1-914-847-7741
email: invest@regeneron.com
irWebSite: https://investor.regeneron.com

Adresse

street: 777 Old Saw Mill River Road
city: Tarrytown, New York 10591-6707, USA
phone: +1-914-847-7000
webSite: is.gd/sEAmh8

Finanzen (kurz)

year: 2021 cash: 2885.6000
balanceSheetTotal: 25434.8000 liabilities: 6666.0000
shareCapital: 0.1000 totalShareholdersEquity: 18768.8000
sales: 16071.7000 incomeBeforeTaxes: 9325.8000
netIncome: 8075.3000 cashFlow: 690.8000
employees: 10368 currencyID: 4
units: 1000000 currency: USD
year: 2022 cash: 3105.9000
balanceSheetTotal: 29214.5000 liabilities: 6550.5000
shareCapital: 0.1000 totalShareholdersEquity: 22664.0000
sales: 12172.9000 incomeBeforeTaxes: 4858.8000
netIncome: 4338.4000 cashFlow: 221.3000
currencyID: 4 units: 1000000
currency: USD
year: 2023 cash: 2730.0000
balanceSheetTotal: 33080.2000 liabilities: 7107.1000
shareCapital: 0.1000 totalShareholdersEquity: 25973.1000
sales: 13117.2000 incomeBeforeTaxes: 4199.3000
netIncome: 3953.6000 cashFlow: -381.6000
currencyID: 4 units: 1000000
currency: USD

Finanzen (kurz)

year: 2021
cash: 2885.6000
balanceSheetTotal: 25434.8000
liabilities: 6666.0000
shareCapital: 0.1000
totalShareholdersEquity: 18768.8000
sales: 16071.7000
incomeBeforeTaxes: 9325.8000
netIncome: 8075.3000
cashFlow: 690.8000
employees: 10368
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 3105.9000
balanceSheetTotal: 29214.5000
liabilities: 6550.5000
shareCapital: 0.1000
totalShareholdersEquity: 22664.0000
sales: 12172.9000
incomeBeforeTaxes: 4858.8000
netIncome: 4338.4000
cashFlow: 221.3000
currencyID: 4
units: 1000000
currency: USD
year: 2023
cash: 2730.0000
balanceSheetTotal: 33080.2000
liabilities: 7107.1000
shareCapital: 0.1000
totalShareholdersEquity: 25973.1000
sales: 13117.2000
incomeBeforeTaxes: 4199.3000
netIncome: 3953.6000
cashFlow: -381.6000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 29214.5000 cash: 3105.9000
currentAssets: 15884.1000 fixedAssets: 13330.4000
liabilities: 3141.3000 totalLiabilitiesEquity: 29214.5000
totalShareholdersEquity: 22664.0000 property: 3763.0000
intangibleAssets: 915.5000 longTermInvestments: 6591.8000
inventories: 2401.9000 accountsReceivable: 5328.7000
accountsPayable: 589.2000 liabilitiesTotal: 6550.5000
longTermDebt: 2701.4000 shortTermDebt: 0.0000
commonStock: 0.1000 preferredStock: 0.0000
sales: 12172.9000 netIncome: 4338.4000
operatingResult: 4738.9000 incomeInterest: -59.4000
investments: 3592.5000 incomeTaxes: 520.4000
costGoodsSold: 1560.4000 grossProfit: 10612.5000
cashFlow: 5014.9000 cashFlowInvesting: -3784.6000
cashFlowFinancing: -1009.0000 cashFlowTotal: 221.3000
accountingStandard: US GAAP equityRatio: 77.5779
debtEquityRatio: 0.1192 liquidityI: 0.9887
liquidityII: 2.6851 netMargin: 35.6398
grossMargin: 87.1814 cashFlowMargin: 41.1972
ebitMargin: 38.9299 ebitdaMargin: 0.0000
preTaxROE: 21.4384 preTaxROA: 16.6315
roe: 19.1423 roa: 14.8502
netIncomeGrowth: -46.2757 revenuesGrowth: -24.2588
taxExpenseRate: 10.7105 equityTurnover: 0.5371
epsBasic: 40.5100 epsDiluted: 38.2200
epsBasicGrowth: -46.9764 shareCapital: 0.1000
incomeBeforeTaxes: 4858.8000 priceEarningsRatioCompany: 17.8102
priceCashFlowRatio: 15.4670 bookValuePerShare: 210.8134
marketCap: 77565503925.1400 earningsYield: 5.6148
pegRatio: -0.3791 cashFlowPerShare: 46.6470
priceBookValueRatio: 3.4224 priceEarningsRatio: 17.8788
netEarningsPerShare: 40.3544 currency: USD
year: 2023 units: 1000000
balanceSheetTotal: 33080.2000 cash: 2730.0000
currentAssets: 19479.2000 fixedAssets: 13601.0000
liabilities: 3423.4000 totalLiabilitiesEquity: 33080.2000
totalShareholdersEquity: 25973.1000 property: 4146.4000
intangibleAssets: 1038.6000 longTermInvestments: 5396.5000
inventories: 2580.5000 accountsReceivable: 5667.3000
accountsPayable: 606.6000 liabilitiesTotal: 7107.1000
longTermDebt: 2702.9000 shortTermDebt: 0.0000
commonStock: 0.1000 preferredStock: 0.0000
sales: 13117.2000 netIncome: 3953.6000
operatingResult: 4047.1000 incomeInterest: -73.0000
investments: 4439.0000 incomeTaxes: 245.7000
costGoodsSold: 1815.8000 grossProfit: 11301.4000
cashFlow: 4594.0000 cashFlowInvesting: -3185.1000
cashFlowFinancing: -1790.1000 cashFlowTotal: -381.6000
accountingStandard: US GAAP equityRatio: 78.5155
debtEquityRatio: 0.1041 liquidityI: 0.7975
liquidityII: 2.4529 netMargin: 30.1406
grossMargin: 86.1571 cashFlowMargin: 35.0227
ebitMargin: 30.8534 ebitdaMargin: 0.0000
preTaxROE: 16.1679 preTaxROA: 12.6943
roe: 15.2219 roa: 11.9516
netIncomeGrowth: -8.8696 revenuesGrowth: 7.7574
taxExpenseRate: 5.8510 equityTurnover: 0.5050
epsBasic: 37.0500 epsDiluted: 34.7700
epsBasicGrowth: -8.5411 shareCapital: 0.1000
incomeBeforeTaxes: 4199.3000 priceEarningsRatioCompany: 23.7055
priceCashFlowRatio: 20.6369 bookValuePerShare: 240.6170
marketCap: 94805916187.5000 earningsYield: 4.2184
pegRatio: -2.7755 cashFlowPerShare: 42.5592
priceBookValueRatio: 3.6502 priceEarningsRatio: 23.9796
netEarningsPerShare: 36.6265 currency: USD
year: 2024 priceEarningsRatioCompany: 20.2489
priceCashFlowRatio: 17.6277 bookValuePerShare: 240.6170
marketCap: 82441323946.8200 earningsYield: 4.9386
pegRatio: -2.3708 cashFlowPerShare: 42.5592
netAssetsPerShare: 240.6170 priceBookValueRatio: 3.1179
priceEarningsRatio: 20.4830 netEarningsPerShare: 36.6265
currency: USD

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 29214.5000
cash: 3105.9000
currentAssets: 15884.1000
fixedAssets: 13330.4000
liabilities: 3141.3000
totalLiabilitiesEquity: 29214.5000
totalShareholdersEquity: 22664.0000
property: 3763.0000
intangibleAssets: 915.5000
longTermInvestments: 6591.8000
inventories: 2401.9000
accountsReceivable: 5328.7000
accountsPayable: 589.2000
liabilitiesTotal: 6550.5000
longTermDebt: 2701.4000
shortTermDebt: 0.0000
commonStock: 0.1000
preferredStock: 0.0000
sales: 12172.9000
netIncome: 4338.4000
operatingResult: 4738.9000
incomeInterest: -59.4000
investments: 3592.5000
incomeTaxes: 520.4000
costGoodsSold: 1560.4000
grossProfit: 10612.5000
cashFlow: 5014.9000
cashFlowInvesting: -3784.6000
cashFlowFinancing: -1009.0000
cashFlowTotal: 221.3000
accountingStandard: US GAAP
equityRatio: 77.5779
debtEquityRatio: 0.1192
liquidityI: 0.9887
liquidityII: 2.6851
netMargin: 35.6398
grossMargin: 87.1814
cashFlowMargin: 41.1972
ebitMargin: 38.9299
ebitdaMargin: 0.0000
preTaxROE: 21.4384
preTaxROA: 16.6315
roe: 19.1423
roa: 14.8502
netIncomeGrowth: -46.2757
revenuesGrowth: -24.2588
taxExpenseRate: 10.7105
equityTurnover: 0.5371
epsBasic: 40.5100
epsDiluted: 38.2200
epsBasicGrowth: -46.9764
shareCapital: 0.1000
incomeBeforeTaxes: 4858.8000
priceEarningsRatioCompany: 17.8102
priceCashFlowRatio: 15.4670
bookValuePerShare: 210.8134
marketCap: 77565503925.1400
earningsYield: 5.6148
pegRatio: -0.3791
cashFlowPerShare: 46.6470
priceBookValueRatio: 3.4224
priceEarningsRatio: 17.8788
netEarningsPerShare: 40.3544
currency: USD
year: 2023
units: 1000000
balanceSheetTotal: 33080.2000
cash: 2730.0000
currentAssets: 19479.2000
fixedAssets: 13601.0000
liabilities: 3423.4000
totalLiabilitiesEquity: 33080.2000
totalShareholdersEquity: 25973.1000
property: 4146.4000
intangibleAssets: 1038.6000
longTermInvestments: 5396.5000
inventories: 2580.5000
accountsReceivable: 5667.3000
accountsPayable: 606.6000
liabilitiesTotal: 7107.1000
longTermDebt: 2702.9000
shortTermDebt: 0.0000
commonStock: 0.1000
preferredStock: 0.0000
sales: 13117.2000
netIncome: 3953.6000
operatingResult: 4047.1000
incomeInterest: -73.0000
investments: 4439.0000
incomeTaxes: 245.7000
costGoodsSold: 1815.8000
grossProfit: 11301.4000
cashFlow: 4594.0000
cashFlowInvesting: -3185.1000
cashFlowFinancing: -1790.1000
cashFlowTotal: -381.6000
accountingStandard: US GAAP
equityRatio: 78.5155
debtEquityRatio: 0.1041
liquidityI: 0.7975
liquidityII: 2.4529
netMargin: 30.1406
grossMargin: 86.1571
cashFlowMargin: 35.0227
ebitMargin: 30.8534
ebitdaMargin: 0.0000
preTaxROE: 16.1679
preTaxROA: 12.6943
roe: 15.2219
roa: 11.9516
netIncomeGrowth: -8.8696
revenuesGrowth: 7.7574
taxExpenseRate: 5.8510
equityTurnover: 0.5050
epsBasic: 37.0500
epsDiluted: 34.7700
epsBasicGrowth: -8.5411
shareCapital: 0.1000
incomeBeforeTaxes: 4199.3000
priceEarningsRatioCompany: 23.7055
priceCashFlowRatio: 20.6369
bookValuePerShare: 240.6170
marketCap: 94805916187.5000
earningsYield: 4.2184
pegRatio: -2.7755
cashFlowPerShare: 42.5592
priceBookValueRatio: 3.6502
priceEarningsRatio: 23.9796
netEarningsPerShare: 36.6265
currency: USD
year: 2024
priceEarningsRatioCompany: 20.2489
priceCashFlowRatio: 17.6277
bookValuePerShare: 240.6170
marketCap: 82441323946.8200
earningsYield: 4.9386
pegRatio: -2.3708
cashFlowPerShare: 42.5592
netAssetsPerShare: 240.6170
priceBookValueRatio: 3.1179
priceEarningsRatio: 20.4830
netEarningsPerShare: 36.6265
currency: USD